Effects of Smoking on the Prevalence of Self-Reported Antihypertensive Medication Use Among Community-Dwelling Stroke Survivors
Author(s)
Coulibaly N
Brown University, Chicago, IL, USA
Presentation Documents
OBJECTIVES:
To evaluate the effects of cigarette smoking on the prevalence of antihypertensive medication use among community-dwelling stroke survivors.METHODS:
Using the 2019 Behavioral Risk Factor Surveillance System survey, the prevalence of antihypertensive medication use was ascertained in stroke survivors with self-reported hypertension by smoking status. Among 9,946 stroke survivors aged ≥65 years, we compared antihypertensive medication use by smoking status. We used logistic regression to evaluate the odds of anti-hypertensive medication use among smokers and non-smokers. All analyses were adjusted for sex, education, marital status, household income, and self-reported history of diabetes, kidney disease, or asthma.RESULTS:
The prevalence of self-reported antihypertensive medication use was ≈93%. Unadjusted rates of antihypertensive medication use were significantly lower for patients who were current smokers compared with non-smokers (88.8% vs 93.7%, p < 0.001). Respondents who smoked had significantly lower adjusted odds (OR =.56, 95% CI = .46–.69, P=0.001) of antihypertensive medication use. Other predictors of higher and lower antihypertensive medication use in stroke survivors included Black/African American race (OR=2.2, 95% CI = 1.6–3.12, P=0.01), graduating from college or technical school education (OR=0.7, 95% CI = 0.52–0.93, p = 0.01), and a household income of $50,000 or more (OR=1.5, 95% CI = 1.1–2.02, p = 0.01).CONCLUSIONS:
Preventing stroke recurrence in older adults is an essential priority in the United States. This analysis shows that community-dwelling stroke survivors with hypertension who smoke have significantly decreased odds of antihypertensive medication use. More studies are needed to identify other factors associated with the prevalence of antihypertensive medication use in stroke survivors.Conference/Value in Health Info
2023-05, ISPOR 2023, Boston, MA, USA
Value in Health, Volume 26, Issue 6, S2 (June 2023)
Code
PCR150
Topic
Health Policy & Regulatory, Patient-Centered Research
Topic Subcategory
Adherence, Persistence, & Compliance, Health Disparities & Equity, Patient-reported Outcomes & Quality of Life Outcomes
Disease
No Additional Disease & Conditions/Specialized Treatment Areas